Presepsin: A Promising Biomarker for Sepsis
- PMID: 33707884
- PMCID: PMC7922456
- DOI: 10.5005/jp-journals-10071-23741
Presepsin: A Promising Biomarker for Sepsis
Abstract
Sepsis is the most common cause of mortality in non-cardiac ICUs. The quest for early diagnosis and treatment has led to the discovery of many biomarkers. In this issue, Abdelshafey et al. have evaluated presepsin, a novel biomarker for early detection of sepsis. Presepsin is formed by cleavage of N-terminal of soluble CD14 (sCD14) which is a member of the Toll-like receptors (TLRs). Studies have found a higher level of presepsin in septic patients and values above 946 ng/L correlated well with gram-negative bacterial sepsis. How to cite this article: Azim A. Presepsin: A Promising Biomarker for Sepsis. Indian J Crit Care Med 2021;25(2):117-118.
Keywords: Biomarkers; Presepsin; Sepsis.
Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.
Conflict of interest statement
Source of support: Nil Conflict of interest: None
References
-
- Ryoo SM, Han KS, Ahn S, Shin TG, Hwang SY, Chung SP, et al. The usefulness of C-reactive protein and procalcitonin to predict prognosis in septic shock patients: a multicenter prospective registrybased observational study. Sci Rep. 2019;9(1):6579. doi: 10.1038/s41598-019-42972-7. DOI: - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous